| Literature DB >> 26851184 |
Emile E Voest1, Rene Bernards2.
Abstract
Precision treatment with targeted cancer drugs requires the selection of patients who are most likely to benefit from a given therapy. We argue here that the use of a combination of both DNA and transcriptome analyses will significantly improve drug response prediction. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26851184 DOI: 10.1158/2159-8290.CD-15-1321
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397